ACETYLCYSTEINE
RESPIRATORY CYSTIC FIBROSIS·+6
HOSPIRA
Indication
Thick bronchial secretions
Thick bronchial secretions refer to a clinical sign and state of abnormal mucus rheology characterized by hyperviscous, tenacious airway secretions within the tracheobronchial tree. Read more about Thick bronchial secretions
6 drugs 6 manufacturers
Drugs that treat it
Common Thick bronchial secretions therapies.
ACETYLCYSTEINE
MUCOLYTICS·RESPIRATORY CYSTIC FIBROSIS·+6
American Regent
ACETYLCYSTEINE
RESPIRATORY CYSTIC FIBROSIS·+6
APP PHARMACEUTI
ACETYLCYSTEINE
RESPIRATORY CYSTIC FIBROSIS·+6
APP/FRESENIUS K
ACETYLCYSTEINE
MUCOLYTICS·RESPIRATORY CYSTIC FIBROSIS·+6
Hospira
ACETYLCYSTEINE
MUCOLYTICS·RESPIRATORY CYSTIC FIBROSIS·+6
CAMERON PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Thick bronchial secretions preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonThick bronchial secretions refer to a clinical sign and state of abnormal mucus rheology characterized by hyperviscous, tenacious airway secretions within the tracheobronchial tree.
This condition commonly impacts pediatric and adult populations experiencing acute or chronic lower respiratory disorders, such as chronic bronchitis, cystic fibrosis, bronchiectasis, asthma, and severe pneumonia, as well as critically ill patients undergoing mechanical ventilation.
Pathophysiologically, persistent airway inflammation, goblet cell hyperplasia, or mucosal dehydration increases the cross-linking of high-molecular-weight gel-forming mucins and inflammatory cellular debris.
The resulting elevated viscoelasticity impairs normal mucociliary clearance, precipitating luminal airway plugging, ventilation-perfusion mismatch, atelectasis, and an increased susceptibility to secondary bacterial infections.
- nih.gov
Thick bronchial secretions refer to a clinical sign and state of abnormal mucus rheology characterized by hyperviscous, tenacious airway secretions within the tracheobronchial tree This condition commonly impacts pediatric and adult populations experiencing acute or chronic lower respiratory disorders, such as chronic bronchitis, cystic fibrosis, bronchiectasis, asthma, and severe pneumonia, as well as critically ill patients undergoing mechanical ventilation Pathophysiologically, persistent air...
- novapulmonary.com
Thick bronchial secretions refer to a clinical sign and state of abnormal mucus rheology characterized by hyperviscous, tenacious airway secretions within the tracheobronchial tree This condition commonly impacts pediatric and adult populations experiencing acute or chronic lower respiratory disorders, such as chronic bronchitis, cystic fibrosis, bronchiectasis, asthma, and severe pneumonia, as well as critically ill patients undergoing mechanical ventilation Pathophysiologically, persistent air...
Personalize your experience
Follow Thick bronchial secretions and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.